
QumulusAI signs US$240.9M GPU contracts with December capacity handoff
Two unnamed inference customers extend earlier deals, with QumulusAI targeting capacity turnover in December 2026 and early 2027.

The four-year plan covers existing lines in three states, but Entergy has given no installation start date or full project budget.

Two unnamed inference customers extend earlier deals, with QumulusAI targeting capacity turnover in December 2026 and early 2027.

The FDA label covers previously untreated adults with no known 17p deletion after a 282-patient trial against chemoimmunotherapy.
Among 109 treated patients, the median response lasted 12.1 months; the single-arm cohort offers no direct efficacy comparison.
Congress delayed the new 0.4-milligram finished-product threshold to Dec. 11, leaving Tilray's disclosed U.S. drink formats above it.

Minnesota's attorney general says Xcel has not shown its Google agreement protects other customers from service and stranded costs.

The GL1 hole lies about 100 metres southeast of earlier drilling; assays from ten more holes in the completed program remain pending.

The company says the agency has set no new action date, while its U.S. launch target remains conditional on approval.

The Nevada lithium study assumes US$24,000 per tonne of lithium carbonate and US$2.77 billion in first-phase capital.
Bitdeer's Oct. 3 update lists zero pure bitcoin holdings as of Oct. 2 but gives no sale price, proceeds or mining costs.
One petition is active and the other pending review; both would let Florida medical operators sell to adults if voters approve.
TransAlta sought US$19.9M for the first 90 days of a federal emergency order; FERC rejected the proposed allocation of those costs.
The TSX Venture company has issued US$10.5 million of secured convertible notes and will seek shareholder approval for preferred shares on Oct. 14.
We Energies says Oracle would take on part of its required nuclear power purchase; Oracle says the subscription needs Wisconsin commission approval.
About 40 gas units are set for staged deployment from late 2026, with revenue expected to begin in the first quarter of 2027.
Northcliff says the Sept. 23-effective report makes no material change to August's results; it holds 88.5 per cent of the partnership that owns Sisson.
Gold, silver, uranium, lithium, copper and rare earths: the producers, the developers and the projects behind them.
View all
TVA's Clinch River permit took effect Sept. 28; GE Vernova's Sept. 29 release states no equipment price or delivery date.
Medical and pharmaceutical developments, psychedelics, and the research and safety questions around them.
View all
Rebisufligene etisparvovec won U.S. approval on Sept. 17; Ultragenyx gave no date for a European decision.
Technology, computing, crypto and cannabis, and the listed companies moving in them.
View all
The Oct. 1 close follows a 25 million share proposal, but the completion notices give no final ownership percentage or cash proceeds to the parent.
State approvals cleared the Oct. 1 transfer of certain Ohio operations; AYR disclosed no cash proceeds or debt relief figure.
Uranium, lithium, oil and gas, hydrogen and the grid: the fuels and the companies behind them.
View all
Marimaca's Oct. 1 update names no supplier, contracted volume or energization date for its preliminary five-year power framework.

Commerce's Bureau of Industry and Security authorised sales under specified terms; the company did not name an export buyer or shipment date.

The proposed transfer covers seven reactors and related liabilities, but the Sept. 30 notice gives no price or signing date.
Licensed producers, retail, policy, and the psychedelics companies moving through the clinic.
View all
The ARTG's Sept. 15 entry names Jupiter Research as manufacturer; Curaleaf also reports a Sept. 17 New Zealand WAND notification.

Colorado completed its review on Sept. 29; permit issuance requires verified warranties, and DOE mine-plan approval remains pending.

The uncontrolled Canadian trial enrolled 11 patients; seven were evaluable for pain, and validated data analysis remains underway.

Lifted Made closed the Kenosha building sale Sept. 29 and used US$841,110 to repay all its outstanding bank debt.